NDC 80064-141

Vyleesi

Bremelanotide

Vyleesi is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Palatin Technologies. The primary component is Bremelanotide Acetate.

• Product ID: 80064-141_2935c1f6-2000-47a2-aec9-43589ce521de
• NDC: 80064-141
• Product Type: Human Prescription Drug
• Proprietary Name: Vyleesi
• Generic Name: Bremelanotide
• Dosage Form: Injection
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2019-06-21
• Marketing Category: NDA / NDA
• Application Number: NDA210557
• Labeler Name: Palatin Technologies
• Substance Name: BREMELANOTIDE ACETATE
• Active Ingredient Strength: 2 mg/.3mL
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 80064-141-02

2 SYRINGE in 1 CARTON (80064-141-02) > .3 mL in 1 SYRINGE (80064-141-01)

• Marketing Start Date: 2019-06-21
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Vyleesi" or generic name "Bremelanotide"

NDC	Brand Name	Generic Name
64011-701	Vyleesi	bremelanotide
80064-141	Vyleesi	bremelanotide